IMVIF
IMV INC by IMV Inc. (IMVIF)
$00
About IMV INC by IMV Inc. (IMVIF)
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
4
P/E ratio
--
IMV INC by IMV Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
4
P/E ratio
--